Loading...
PREZIES: PREventie van ZIEkenhuisinfecties door Surveillance. Component Lage luchtweginfecties bij beademing, pilot 2003
Citations
Altmetric:
Series / Report no.
RIVM Rapport 210601006
Open Access
Type
Report
Language
nl
Date
2005-01-27
Research Projects
Organizational Units
Journal Issue
Title
PREZIES: PREventie van ZIEkenhuisinfecties door Surveillance. Component Lage luchtweginfecties bij beademing, pilot 2003
Translated Title
PREZIES: prevention of hospital-acquired infections through surveillance. Pilot module for Ventilator-associated lower respiratory tract infections, 2003
Published in
Abstract
De surveillance van beademing-gerelateerde pneumonieen volgens het protocol van het samenwerkingsverband PREventie van ZIEkenhuisinfecties door Preventie (PREZIES) is met name geschikt voor 'grotere' ziekenhuizen. Dit is de conclusie van de drie maanden durende pilotstudie voor de surveillance van 'Beademing-gerelateerde lage luchtweginfecties', waaraan drie ziekenhuizen meededen. Het doel van deze pilotstudie was te achterhalen in hoeverre de gehanteerde criteria en definities helder en bruikbaar waren en of de dataverzameling wat betreft tijdsinvestering haalbaar was. Het protocol is geevalueerd door respectievelijk telefonische interviews met de betrokken ziekenhuishygienisten, een validatiebezoek, data-analyse, een bijeenkomst met deelnemers waar de resultaten werden besproken en de beoordeling van het gewijzigde protocol door experts. De surveillance volgens het protocol verliep goed volgens de ziekenhuishygienisten. De criteria voor bronchitis werden echter niet specifiek gevonden en tevens vond men bronchitis klinisch minder van belang. Bronchitis is daarom niet als uitkomst in het definitieve protocol opgenomen. Non-invasieve beademing en sterfte kunnen volgens dit protocol optioneel geregistreerd worden. Verder werd het protocol op kleine punten aangepast. De instroom, 35 patienten in totaal, was lager dan verwacht. De incidentie bedroeg 5 /1000 beademingsdagen voor zowel pneumonie als bronchitis. Dit is lager dan de pneumonie-incidentie van 24 /1000 beademingsdagen die in een eerdere PREZIES-surveillance, uitgevoerd in 21 ziekenhuizen, gemeten werd. Om met enige betrouwbaarheid inzicht te kunnen krijgen in de incidentie van beademing-gerelateerde pneumonie is het advies dat er per ziekenhuis minstens 100 patienten in de surveillance worden opgenomen. Hiermee is de module 'Beademing-gerelateerde pneumonieen' met name geschikt voor 'grotere' ziekenhuizen.
Surveillance of ventilator-associated pneumonia according to the protocol developed by PREZIES, the national network for the surveillance of nosocomial infections, is particularly suitable for large hospitals. This is the conclusion drawn from the three-month pilot on 'Ventilator-associated lower respiratory tract infections', in which three hospitals participated. This pilot was aimed at ascertaining whether criteria and definitions in the protocol were clear and whether data collection was feasible with respect to the needed time investment. Evaluation took the form of telephone interviews with the responsible infection control practitioner (ICP), a validation visit, data analysis, a meeting of participants to discuss results and, finally, submission of the altered protocol to experts for comments. ICPs experienced no problems in data collection, except for bronchitis. Since the criteria for bronchitis were not specific and bronchitis was considered clinically less interesting, the outcome for bronchitis has been excluded from the final protocol. Non-invasive ventilation and death can be registered optionally according to this protocol. Further adaptations were minor. The total intake of 35 patients was lower than expected. The incidence was 5 /1000 ventilation days for pneumonia as well as bronchitis. This is lower than the pneumonia incidence of 24 /1000 ventilation days which was determined in an earlier PREZIES surveillance, performed in 21 hospitals. To gain insight into the incidence of ventilator-associated pneumonia with a certain reliability, hospitals are advised to take up at least 100 patients in the surveillance. The final version of the module, 'Ventilator-associated pneumonias', can be concluded then as being particularly suitable for large hospitals.
Surveillance of ventilator-associated pneumonia according to the protocol developed by PREZIES, the national network for the surveillance of nosocomial infections, is particularly suitable for large hospitals. This is the conclusion drawn from the three-month pilot on 'Ventilator-associated lower respiratory tract infections', in which three hospitals participated. This pilot was aimed at ascertaining whether criteria and definitions in the protocol were clear and whether data collection was feasible with respect to the needed time investment. Evaluation took the form of telephone interviews with the responsible infection control practitioner (ICP), a validation visit, data analysis, a meeting of participants to discuss results and, finally, submission of the altered protocol to experts for comments. ICPs experienced no problems in data collection, except for bronchitis. Since the criteria for bronchitis were not specific and bronchitis was considered clinically less interesting, the outcome for bronchitis has been excluded from the final protocol. Non-invasive ventilation and death can be registered optionally according to this protocol. Further adaptations were minor. The total intake of 35 patients was lower than expected. The incidence was 5 /1000 ventilation days for pneumonia as well as bronchitis. This is lower than the pneumonia incidence of 24 /1000 ventilation days which was determined in an earlier PREZIES surveillance, performed in 21 hospitals. To gain insight into the incidence of ventilator-associated pneumonia with a certain reliability, hospitals are advised to take up at least 100 patients in the surveillance. The final version of the module, 'Ventilator-associated pneumonias', can be concluded then as being particularly suitable for large hospitals.
Description
Publisher
Rijksinstituut voor Volksgezondheid en Milieu RIVM
CBO
CBO
Sponsors
IGZ
VWS
VWS